14.01.2016
- US drug firm Pfizer is linking with non-profit organization The California Institute for Biomedical Research (Calibr) to develop new heart failure treatments. Calibr said its...
14.01.2016
- French drugmaker Sanofi has simultaneously announced collaborations with two biotechnology firms, together worth up to €1.2 billion. The first link-up, worth $750 million (€690...
